Search This Blog

Thursday, July 30, 2026

Phathom down after beat

 

Phathom Pharmaceuticals beats Q2 2026 estimates with EPS $0.00 (+100% YoY), revenue $74.3M (+88% YoY), updates full-year 2026 guidance

  • Q2 2026 revenue of $74.3M marked a record quarterly level for Phathom Pharmaceuticals.

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)